FTC Demands Drug Divestment For $1.9B Mylan, Agila Merger

By Kat Greene (September 26, 2013, 9:23 PM EDT) -- The Federal Trade Commission on Thursday said it will require Mylan Inc. and Agila Specialties Global Ltd. to divest 11 of their generic injectable drugs if they want to complete their $1.9 billion merger....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!